Clinical Trial Update: Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the safety and efficacy of a fixed-dose combination of fexofenadine HCl and pseudoephedrine HCl in Indian participants aged 12 and abov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Fexofenadine HCl + Pseudoephedrine HCl Fixed-Dose Combination (fexofenadine hydrochloride; pseudoephedrine hydrochloride)

Snippet

Sponsor: Sanofi | Conditions: Rhinitis Allergic | Phase 4 | Status: COMPLETED